caseins has been researched along with d 609 in 1 studies
| Studies (caseins) | Trials (caseins) | Recent Studies (post-2010) (caseins) | Studies (d 609) | Trials (d 609) | Recent Studies (post-2010) (d 609) |
|---|---|---|---|---|---|
| 16,863 | 561 | 4,170 | 270 | 0 | 48 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abalsamo, L; Bozzuto, G; Cecchetti, S; Iorio, E; Lugini, L; Molinari, A; Paris, L; Podo, F; Ramoni, C; Spadaro, F | 1 |
1 other study(ies) available for caseins and d 609
| Article | Year |
|---|---|
Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
Topics: Antigens, CD; Antigens, Surface; Biomarkers, Tumor; Breast Neoplasms; Bridged-Ring Compounds; Cadherins; Caseins; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytoplasm; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Female; Galectin 3; Humans; Mesenchymal Stem Cells; Mesoderm; Milk Proteins; Norbornanes; Phospholipase D; Sphingomyelin Phosphodiesterase; Thiocarbamates; Thiones; Type C Phospholipases; Vimentin | 2012 |